银诺医药-B(02591.HK)拟8月29日举行董事会会议批准中期业绩
Group 1 - The company, Silver诺医药-B (02591.HK), announced that its board meeting will be held on August 29, 2025, to consider and approve the interim results for the six months ending June 30, 2025 [1]
Group 1 - The company, Silver诺医药-B (02591.HK), announced that its board meeting will be held on August 29, 2025, to consider and approve the interim results for the six months ending June 30, 2025 [1]